6 deeply undervalued biotech companies
http://seekingalpha.com/article/293435-6-deeply-undervalued-biotech-companies?source=yahoo
Oncothyreon ONTY is one of them and what Prima is doing is comparable as they both target Mucin-1 in different ways and fir different cancers.
This article is a good example which shows us that with just a list time and sweet greetings by the SEC that our baby should also be getting this visibility.
What with the ASX300, cashed up, Dubai, IIb enrollment completion, III commencement, management, scientific talent/advisory, similarities to Dendreon's technology, oral Gardasil, etc etc, Prima should soon truly start to start turning heads and open up some cheque books.
7 (including pbmd when listed on nasdaq radar)
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.025(6.33%) |
Mkt cap ! $598.3M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 42.0¢ | 39.5¢ | $890.1K | 2.163M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 127863 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 30850 | 2 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |